I know there is some speculation on a potential partnership for MASH. If this does come to fruition, what are some well educated guesses of what the SP may rise to? Are we looking at .50-.75 or something higher or lower than that?
I honestly have no idea and hope to hear what others who have been in biotech have to say.

Here’s to a prosperous 2025!